ReShape Lifesciences Total Long-Term Assets 2015-2024 | RSLS

ReShape Lifesciences total long-term assets from 2015 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current

ReShape Lifesciences Total Long-Term Assets 2015-2024 | RSLS

ReShape Lifesciences total long-term assets from 2015 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$197.4B
Intuitive Surgical (ISRG)$196.1B
Alcon (ALC)$42.2B
Edwards Lifesciences (EW)$41.5B
IQVIA Holdings (IQV)$35.9B
IDEXX Laboratories (IDXX)$34.3B
DexCom (DXCM)$29.1B
Waters (WAT)$21.9B
STERIS (STE)$21.3B
SONOVA HOLDING (SONVY)$20.5B
Hologic (HOLX)$18.3B
Fresenius Medical Care AG KGaA (FMS)$12.9B
Sysmex ADR (SSMXY)$12.8B
Globus Medical (GMED)$11.6B
Penumbra (PEN)$9.2B
Masimo (MASI)$9.1B
Teleflex (TFX)$8.9B
Glaukos (GKOS)$7.8B
PROCEPT BioRobotics (PRCT)$4.9B
Integer Holdings (ITGR)$4.6B
Veracyte (VCYT)$3B
Inari Medical (NARI)$2.9B
LivaNova (LIVN)$2.8B
TransMedics (TMDX)$2.7B
Nihon Kohden (NHNKY)$2.4B
Elekta AB (EKTAY)$2.1B
Tandem Diabetes Care (TNDM)$2B
RxSight (RXST)$1.8B
Integra LifeSciences Holdings (IART)$1.8B
Alphatec Holdings (ATEC)$1.4B